User profiles for Adam Trickey
 | Adam TrickeyUniversity of Bristol Verified email at bristol.ac.uk Cited by 6051 |
[HTML][HTML] Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage …
Background Sharing of equipment used for injecting drug use (IDU) is a substantial cause
of disease burden and a contributor to blood-borne virus transmission. We did a global …
of disease burden and a contributor to blood-borne virus transmission. We did a global …
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study
Background WHO aims to eliminate the hepatitis C virus (HCV) as a public health threat by
2030. Injection drug use is an important risk factor for HCV transmission, but its contribution to …
2030. Injection drug use is an important risk factor for HCV transmission, but its contribution to …
[HTML][HTML] Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Background Health care for people living with HIV has improved substantially in the past
two decades. Robust estimates of how these improvements have affected prognosis and life …
two decades. Robust estimates of how these improvements have affected prognosis and life …
[HTML][HTML] Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
…, HH Kyu, E Gakidou, SI Hay, EJ Mills, A Trickey… - The lancet HIV, 2016 - thelancet.com
Background Timely assessment of the burden of HIV/AIDS is essential for policy setting and
programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD …
programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD …
[HTML][HTML] Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis
Background Increasing access to hepatitis C virus (HCV) care and treatment will require
simplified service delivery models. We aimed to evaluate the effects of decentralisation and …
simplified service delivery models. We aimed to evaluate the effects of decentralisation and …
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
Background and Aims People who have recently injected drugs are a priority population in
efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence …
efforts to achieve hepatitis C virus (HCV) elimination. This study estimated the prevalence …
[HTML][HTML] Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
…, H Fraser, AA Artenie, S Bivegete, A Trickey… - The Lancet public …, 2021 - thelancet.com
Background People who inject drugs (PWID) are at increased risk for HIV and hepatitis C
virus (HCV) infection and also have high levels of homelessness and unstable housing. We …
virus (HCV) infection and also have high levels of homelessness and unstable housing. We …
[HTML][HTML] Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
Background People who inject drugs (PWID) experience a high prevalence of incarceration
and might be at high risk of HIV and hepatitis C virus (HCV) infection during or after …
and might be at high risk of HIV and hepatitis C virus (HCV) infection during or after …
[HTML][HTML] Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
Background The life expectancy of people with HIV taking antiretroviral therapy (ART) has
increased substantially over the past 25 years. Most previous studies of life expectancy were …
increased substantially over the past 25 years. Most previous studies of life expectancy were …
[HTML][HTML] Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and …
A Trickey, E Fajardo, D Alemu, AA Artenie… - The lancet …, 2023 - thelancet.com
Background Point-of-care (POC) hepatitis C virus (HCV) RNA nucleic acid test viral load
assays are being used increasingly as an alternative to centralised, laboratory-based standard-…
assays are being used increasingly as an alternative to centralised, laboratory-based standard-…